Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab. (7th November 2013) - Callahan, Margaret K; Horak, Christine E; Curran, Michael A; Hollman, Travis; Schaer, David A; Yuan, Jianda; Lesokhin, Alexander M; Kitano, Shigehisa; Hong, Quan; Ariyan, Charlotte E; Busam, Klaus J; Feely, William; et al.